SCHEMBL4550651

SCHEMBL4550651

CCCCCNC(CO)C(O)CCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
KDM4E B2RXH2 2/20 0.53
ASAH1 Q13510 1/20 0.53
ALDH1A1 P00352 1/20 0.53
SPHK1 Q9NYA1 3/20 0.48
CYP2D6 P10635 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
GMNN O75496 1/20 0.48
POLB P06746 1/20 0.48
THPO P40225 1/20 0.48
MTOR P42345 1/20 0.48
BLM P54132 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CETP P11597 1/20 0.48
HTT P42858 1/20 0.48
UBE2N P61088 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28696485 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL4432269 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL30368691 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL898809 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL15239749 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL30432362 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL5718656 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL2727470 0.98 MEN1 (0.57) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL6237363 0.89 KDM4E (0.67) MEN1KMT2AKDM4EASAH1ALDH1A1
SCHEMBL8815031 0.89 KDM4E (0.67) MEN1KMT2AKDM4EASAH1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4226808-A 1-Aryl-2-dihalogenodeuterioalkanoylamido-1,3-propanediol antibacterial agents SCHERING CORPORATION (US) 1980-10-07 US claimed
US-7518017-B2 Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds IDEXX LABORATORIES (US) 2009-04-14 US disclosed
US-7518017-B2 Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds IDEXX LABORATORIES (US) 2009-04-14 US disclosed
EP-1953138-A3 Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds IDEXX LABORATORIES, INC. (US) 2008-10-08 EP disclosed
EP-1953138-A2 Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds IDEXX LABORATORIES, INC. (US) 2008-08-06 EP disclosed
EP-1953138-A2 Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds IDEXX LABORATORIES, INC. (US) 2008-08-06 EP disclosed
US-20070197823-A1 Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds IDEXX LABORATORIES, INC. 2007-08-23 US disclosed
US-20070197823-A1 Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds IDEXX LABORATORIES, INC. 2007-08-23 US disclosed
US-4361557-A 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor SCHERING CORPORATION (US) 1982-11-30 US disclosed
US-4311857-A 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their manufacture and intermediates useful therein, methods for their use as antibacterial agents and compositions useful therefor SCHERING CORPORATION (US) 1982-01-19 US disclosed
US-4235892-A AROMATIC ANTIBIOTICS Schering Corporation, Patent Dept. (US) 1980-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197823-A1 Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds ADRB1, ADRB2, ADRA1A MEN1 1186/4885KMT2A 2706/4885KDM4E 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.